Orexigen Therapeutics Inc (OREXQ)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Michael A. Narachi
Employees:
132
3344 N. TORREY PINES CT., SUITE 200, LA JOLLA, CA 92037
(858) 875-8600

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities includes recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA.

Data derived from most recent annual or quarterly report
Market Cap 83.019 Thousand Shares Outstanding16.604 Million Avg 30-day Volume 217.058 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-8.02
Price to Revenue0.0 Debt to Equity-0.4067 EBITDA-162.693 Million
Price to Book Value0.0 Operating Margin-214.5683 Enterprise Value0
Current Ratio1.997 EPS Growth-0.645 Quick Ratio1.595
1 Yr BETA -0.6867 52-week High/Low 0.0 / Profit Margin-192.6534
Operating Cash Flow Growth-48.1085 Altman Z-Score0.0 Free Cash Flow to Firm -68.28 Million
View SEC Filings from OREXQ instead.

View recent insider trading info

Orexigen Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding OREXQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OREXQ

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2019-06-04 by BAUPOST GROUP LLC
  • 4: filed on 2018-10-31 by BAUPOST GROUP LLC
  • 4: filed on 2018-10-26 by BAUPOST GROUP LLC
  • 4: filed on 2018-04-26 by BAUPOST GROUP LLC
  • 4: filed on 2018-03-16 by MOGLIA STEPHEN A.
  • 4: filed on 2017-10-17 by LYNCH THOMAS P.
  • 4: filed on 2017-10-17 by KEYES JASON A
  • 4: filed on 2017-10-17 by FLYNN PETER D
  • 4: filed on 2017-10-17 by CANNELL THOMAS R
  • 4: filed on 2017-10-17 by NARACHI MICHAEL

    • Events (8k)

  • 8-K: filed on 2019-05-03:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-02-05:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-12-14:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-10-31:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-05-04:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-04-24:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-04-13:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-04-02:
    Item 8.01: Other Events
  • 8-K: filed on 2018-03-12:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.03: Bankruptcy or Receivership
    Item 2.02: Results of Operations and Financial Condition
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-02-28:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    BAUPOST GROUP LLC/MA

    BAUPOST GROUP GP, L.L.C.

    KLARMAN SETH A

    • 10% Owner
    		 No longer subject to file 2019-05-31 0

    MOGLIA STEPHEN A. VP & CHIEF ACCOUNTING OFFICER

    • Officer
    		 0 2018-03-15 0

    FORBES MONICA VP & ACTING CFO

    • Officer
    		 0 2018-02-27 0

    NARACHI MICHAEL CEO & PRESIDENT

    • Officer
    • Director
    		 0 2017-10-13 0

    FLYNN PETER D EVP, HEAD OF GLOBAL DEV

    • Officer
    		 0 2017-10-13 0

    CANNELL THOMAS R EVP, COO, PRES GLOBAL COM PROD

    • Officer
    		 0 2017-10-13 0

    LYNCH THOMAS P. EVP, CHIEF ADMIN OFF, GC & SEC

    • Officer
    		 0 2017-10-13 0

    KEYES JASON A EVP, CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2017-10-13 0

    DOVEY BRIAN H

    • Director
    		 0 2017-07-14 0

    MAHAFFY PATRICK J

    • Director
    		 0 2017-07-14 0

    ZOTH LOTA S.

    • Director
    		 0 2017-07-14 0

    BOCK LOUIS C

    • Director
    		 0 2017-07-14 0

    HONIG PETER

    • Director
    		 0 2017-07-14 0

    ENDICOTT DAVID J.

    • Director
    		 0 2017-07-14 0

    JORN DEBORA

    • Director
    		 0 2017-07-14 0

    BAUPOST GROUP LLC/MA

    SAK CORP

    KLARMAN SETH A

    • 10% Owner
    		 22,268,399 2016-03-15 0

    KLASSEN PRESTON EVP, GLOBAL DEVELOPMENT

    • Officer
    		 10,160 2016-02-02 0

    ACE HEATHER S EVP, GLOBAL HUMAN RESOURCES

    • Officer
    		 0 2016-02-02 0

    DIXON WENDY L

    • Director
    		 0 2015-06-09 0

    WEBER ECKARD

    • Director
    		 0 2015-06-09 0

    BOOTH MARK D CHIEF COMMERCIAL OFFICER

    • Officer
    		 3,810 2015-02-26 0

    TURNER HEATHER D SVP, GEN. COUNSEL & SECRETARY

    • Officer
    		 0 2015-02-03 0

    HAGAN JOSEPH P CHIEF BUSINESS OFFICER

    • Officer
    		 0 2015-02-03 0

    TREU JESSE I

    • 10% Owner
    		 3,487,205 2011-12-22 0

    BLAIR JAMES C

    • 10% Owner
    		 3,487,205 2011-12-22 0

    VITULLO NICOLE

    • 10% Owner
    		 3,487,205 2011-12-22 0

    SCHOEMAKER KATHLEEN K

    • 10% Owner
    		 3,487,205 2011-12-22 0

    TURNER DANIEL K III

    • Director
    		 613,120 2011-12-22 0

    HALAK BRIAN K

    • 10% Owner
    		 3,487,205 2011-12-22 0

    DP VII ASSOCIATES LP

    • 10% Owner
    		 58,525 2011-12-22 0

    DOMAIN PARTERS VII L P

    • 10% Owner
    		 3,428,680 2011-12-22 0

    VIVEASH DAWN SVP/HEAD OF REGULATORY AFFAIRS

    • Officer
    		 0 2011-07-22 0

    POWELL MICHAEL

    • Director
    		 0 2011-06-02 0

    LACOB JOSEPH

    • Director
    		 0 2011-05-27 0

    COOPER GRAHAM K CFO AND TREASURER

    • Officer
    		 0 2011-01-18 0

    KAMDAR KIM P.

    • 10% Owner
    		 1,963 2011-01-01 0

    BREEN DORON

    SPHERA FUNDS MANAGEMENT LTD.

    MOR ISRAEL

    SENATOR RON

    • MEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUP
    		 591,877 2010-08-06 0

    ARKIN MOSHE

    M. ARKIN (1999) LTD.

    • MEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUP
    		 No longer subject to file 2010-07-12 0

    DUNAYEVICH EDUARDO CHIEF MEDICAL OFFICER

    • Officer
    		 0 2010-01-22 0

    PISKORSKI WALTER SVP, TECHNICAL OPERATIONS

    • Officer
    		 0 2010-01-22 0

    SCAIFE MICHAEL C SR. VP, REGULATORY AFFAIRS

    • Officer
    		 0 2009-05-27 0

    BAUM CAROL A VP, COMMERCIALIZATION

    • Officer
    		 0 2009-04-23 0

    KIM DENNIS D SR. VP, CORPORATE DEVELOPMENT

    • Officer
    		 0 2009-04-23 0

    LANDBLOOM RONALD P VP, MEDICAL AND REGULATORY

    • Officer
    		 0 2009-01-26 0

    COWLEY MICHAEL A CHIEF SCIENTIFIC OFFICER

    • Officer
    		 141,344 2008-08-28 0

    BYMASTER FRANKLIN P VP, NEUROSCIENCE

    • Officer
    		 0 2008-08-27 0

    MCKINNEY ANTHONY A CHIEF BUSINESS OFFICER

    • Officer
    		 0 2008-08-27 0

    TOLLEFSON GARY D PRESIDENT AND CEO

    • Officer
    • Director
    		 0 2008-08-15 0

    LANCASTER JAMES C JR VP OF COMMERCIAL OPERATIONS

    • Officer
    		 31,500 2007-12-26 0

    DOMAIN ASSOCIATES

    • 10% Owner
    		 1,963 2007-11-27 0

    DP V ASSOCIATES LP

    • 10% Owner
    		 83,975 2007-11-27 0

    DOMAIN PARTNERS V LP

    • 10% Owner
    		 3,543,832 2007-11-27 0

    MORE ROBERT J

    • 10% Owner
    		 3,646,376 2007-11-27 0

    SCALE VENTURE PARTNERS II, LP

    SCALE VENTURE MANAGEMENT II, LLC

    • 10% Owner
    		 2,717,445 2007-11-21 0

    KLEINER PERKINS CAUFIELD & BYERS X A LP

    • 10% Owner
    		 3,735,402 2007-05-01 0

    KLEINER PERKINS CAUFIELD & BYERS X B LP

    • 10% Owner
    		 72,642 2007-05-01 0

    SOFINNOVA VENTURE PARTNERS VI L P

    • 10% Owner
    		 6,231,944 2007-05-01 0

    KPCB X ASSOCIATES LLC

    • 10% Owner
    		 5,278,804 2007-05-01 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments